Health Status after Transcatheter Mitral Valve Repair in Patients with Heart Failure and Secondary Mitral Regurgitation: COAPT Trial

BACKGROUND: In the COAPT trial, transcatheter mitral valve repair (TMVr) with the edge-to-edge device led to reduced heart failure (HF) hospitalizations and improved survival in patients with symptomatic HF and 3-4+ secondary mitral regurgitation (MR) on maximally-tolerated medical therapy. Given th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Am Coll Cardiol
Main Authors: Arnold, Suzanne V., Chinnakondepalli, Khaja M., Spertus, John A., Magnuson, Elizabeth A., Baron, Suzanne J., Kar, Saibal, Lim, D. Scott, Mishell, Jacob M., Abraham, William T., Lindenfeld, JoAnn A., Mack, Michael J., Stone, Gregg W., Cohen, David J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6499691/
https://ncbi.nlm.nih.gov/pubmed/30894288
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacc.2019.02.010
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados